In their commentary1 about our report2 and a similar Finnish report3 on the treatment of acute otitis media in young children, Drs Marmor and Newman ignored or misread crucial elements. Although the commentary was aptly titled, ‘Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media…,’ the text applicable to our trial was limited to a discussion of the differences we found between the amoxicillin-clavulanate and placebo treatment groups in symptomatic response, without reference to …